Free Newsletter
BMS stockholders flock to spinoff offer
Free newsletter via e-mail
Tools
Bristol-Myers Squibb said its stock-swap offer as part of its spinoff of Mead Johnson Nutrition attracted nearly twice as many shares as it can exchange, so holders who tendered at least 100 shares will get 53.8 percent swapped for Mead Johnson stock. Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: